Pharmaceutical Technology2 天
Risk adjusted net present value: What is the current valuation of Philogen’s Fibromun?
Fibromun is a fusion protein commercialized by Philogen, with a leading Phase III program in Soft Tissue Sarcoma.
Nature5 年
Diagnosis | Rhabdomyosarcoma
On the basis of these immunohistochemical findings and our histological findings, we classified the tumor as a rhabdomyosarcoma. Figure 3: Immunohistochemical staining of the spindle cell tumor in ...
Pharmaceutical Technology5 天
Risk adjusted net present value: What is the current valuation of AstraZeneca’s Volrustomig?
Volrustomig is a monoclonal antibody commercialized by AstraZeneca, with a leading Phase III program in Malignant Pleural Mesothelioma.
India Today on MSN1 个月
At 24, TikToker Bella Bradford dies of rhabdomyosarcoma: All about this rare cancer
Bella Bradford, an Australian TikTok star, died on October 15 from a rare type of cancer called rhabdomyosarcoma. She had ...